Personal Details | |
---|---|
Doctor Name | Sumant Gupta |
Primary Specialty | Oncology |
Experience | 15 Years |
Education & Training | MBBS, MD - Internal Medicine, DM (Medical Oncology) |
Medical Education | SSMC, Tumkur, Rajiv Gandhi University of Health Sciences Karnataka, India |
Residency | Faridabad |
Practice Areas | Metro Heart Institute with Multispecialty Faridabad |
Certifications | Medical Council of India |
Dr. Sumant Gupta, a highly regarded cancer specialist, possesses extensive experience in treating various types of cancers. He received his training from the Cancer Institute (WIA) in Adyar, Chennai, and the All India Institute of Medical Sciences (AIIMS). His area of specialization includes Hematological, Malignancies & Bone Marrow Transplants.
Dr. Gupta is recognized for conducting Faridabad’s initial-ever Bone Marrow Transplant. He has over 20 national and international publications to his credit. Currently, he serves as an executive committee member of the Indian Society of Oncology & Breast Cancer Foundation-India.
Education
- DM (Medical Oncology) – Cancer Institute (WIA) Adyar, Chennai
- MD (Internal Medicine) – Chaudhary Charan Singh University, Meerut (UP)
- MBBS – SSMC, Tumkur, Rajiv Gandhi University of Health Sciences Karnataka, India
Area of Interest
- Parotid Surgery
- Chemotherapy of Haematological Malignancies
- Breast Cancer Treatment
- Lung Cancer Treatment
- Melanoma Treatment
- Head and Neck Tumor / Cancer Surgery
- Stem Cell Transplantation
- Giant Cell tumour Treatment
- PICC Line Insertion
- Osteosarcoma Treatment
- Chemotherapy of Solid Tumors
- Breast Cancer Management
Membership/Awards
- TYSA Young Scholar Award for the Best DM – Medical Oncology, 2015.
- Winner of TYACON Quiz at the Annual Conference of Teen and young oncology 2013 in Delhi.
- Molecular Biology of Lung Cancer—A Review- Indian Journal of Surgical Oncology
- Neutrophil response kinetics after G-CSF and Pef G-CSF usage post-chemotherapy, Journal of Clinical Oncology
- Feasibility of combining humanized anti-epidermal growth factor receptor monoclonal hR3 (nimotuzumab) with chemotherapy- A study of toxicity profile and tolerance, Journal of Clinical Oncology
Experience
Dr Sumant Gupta was formerly associated with HOD & Senior Consultant – Sarvodaya Cancer Institute, Associate Consultant Medical Oncology at Batra Hospital, Senior Registrar at Department of Medical Oncology at All India Institute of Medical Sciences, New Delhi